You searched for "infections"
Do patient demographics influence AMD clinic attendance during COVID-19 lockdown?
The authors assess the impact of the COVID-19 pandemic on adherence to scheduled clinic appointments among age-related macular degeneration patients in a clinic in North Wales. The COVID-19 pandemic has significantly affected the population, affecting economic and social wellbeing, whilst...Global sight alliance declares climate emergency
In recognition of Earth Day, on 22 April 2021, the International Agency for the Prevention of Blindness (IAPB) has declared a Climate Emergency and released a call to action for environmentally sustainable practices in the eye health sector.Virtual reality is revolutionising healthcare
From mental health therapies to surgical training, virtual reality is revolutionising healthcare, finds GlobalData.WATCH EPISODE 8: Beyond 2020 with the Andean Medical Mission
This video is for medical teams and NGOs who are working to eliminate avoidable blindness in remote village settings where the risk of an infection post-surgery is high.
Effect of preservative free fluoroquinolones on human corneal epithelial cells in vitro
Fluoroquinolones, including second generation (ofloxacin and ciprofloxacin), third generation (levofloxacin and tosufloxacin) and fourth generation (gatifloxacin and moxifloxacin), are a group of bactericidal agents used to treat multiple ocular infections. The third and fourth generation fluoroquinolones have enhanced Gram-positive activity...
Neurotrophic keratitis
The authors present an overview of the aetiology, diagnosis, current and future management options of neurotrophic keratitis. This is a degenerative corneal disease that occurs following the compromise of trigeminal innervation, leading to hypoesthesia and / or anaesthesia. The aetiology...
CMV assessment
This is a retrospective, cross-sectional review of medical records from a consecutive series of patients with AIDS-related cytomegalovirus (CMV) retinitis who were examined at five HIV disease clinics in Yangon, Myanmar, in November 2006. All patients with CD4+ T lymphocytes...
